BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38081464)

  • 21. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
    To TM; Exuzides A; Abbass IM; Patel AM; Ta JT; Surinach A; Fuller RLM; Luo J
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1228-1239. PubMed ID: 36282937
    [No Abstract]   [Full Text] [Related]  

  • 23. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.
    Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK
    J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
    Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
    Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Cost Sarcoidosis Patients in the United States: Patient Characteristics and Patterns of Health Care Resource Utilization.
    Rice JB; White A; Lopez A; Nelson WW
    J Manag Care Spec Pharm; 2017 Dec; 23(12):1261-1269. PubMed ID: 29172980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
    Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
    J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Care Resource Utilization in Management of Opioid-Naive Patients With Newly Diagnosed Neck Pain.
    Jin MC; Jensen M; Zhou Z; Rodrigues A; Ren A; Barros Guinle MI; Veeravagu A; Zygourakis CC; Desai AM; Ratliff JK
    JAMA Netw Open; 2022 Jul; 5(7):e2222062. PubMed ID: 35816312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis.
    Fuldeore M; Yang H; Soliman AM; Winkel C
    Curr Med Res Opin; 2015; 31(9):1719-31. PubMed ID: 26153675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare utilization and costs for spinal conditions in Ontario, Canada - opportunities for funding high-value care: a retrospective cohort study.
    Rampersaud YR; Power JD; Perruccio AV; Paterson JM; Veillette C; Coyte PC; Badley EM; Mahomed NN
    Spine J; 2020 Jun; 20(6):874-881. PubMed ID: 32007652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active Duty Service Members Newly Presenting With Low Back Pain in Fiscal Year 2017: Health Care Utilization, Access to Care, and Private Sector Costs Over 2-year Follow-up.
    Yuan X; Pav V; Colahan C; Miller ME; Hager NA; Pasquina PF; Cohen SP; Isaacson BM
    Mil Med; 2023 Jul; 188(7-8):e2387-e2396. PubMed ID: 36433751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
    Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
    J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States.
    Park PW; Dryer RD; Hegeman-Dingle R; Mardekian J; Zlateva G; Wolff GG; Lamerato LE
    Pain Pract; 2016 Nov; 16(8):1001-1011. PubMed ID: 26443292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
    Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
    J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
    [No Abstract]   [Full Text] [Related]  

  • 39. Costs associated with febrile neutropenia in the US.
    Michels SL; Barron RL; Reynolds MW; Smoyer Tomic K; Yu J; Lyman GH
    Pharmacoeconomics; 2012 Sep; 30(9):809-23. PubMed ID: 22804805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis.
    Trantham L; Sikirica MV; Candrilli SD; Benson VS; Mohan D; Neil D; Joshi AV
    J Med Econ; 2019 Apr; 22(4):319-327. PubMed ID: 30580639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.